Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 60945 

consult with legal counsel and the 

program office on next steps regarding 

the prohibited equipment or services. 

C. Annual Burden 

Respondents: 902,777. 

Total Annual Responses: 905,213. 

Total Burden Hours: 1,839,573. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 88 FR 42367, on 

June 30, 2023. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division, by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0199, Prohibition on 

Contracting for Certain 

Telecommunications and Video 

Surveillance Services or Equipment. 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2023–19148 Filed 9–5–23; 8:45 am] 

BILLING CODE 6820–EP–P 

GENERAL SERVICES 

ADMINISTRATION 

GSA Acquisition Policy Federal 

Advisory Committee; Notification of 

Upcoming Web-Based Public Meeting 

AGENCY: Office of Government-Wide 

Policy (OGP), General Services 

Administration (GSA). 

ACTION: Meeting notice. 

SUMMARY: GSA is providing notice of a 

meeting of the GSA Acquisition Policy 

Federal Advisory Committee 

(hereinafter ‘‘the Committee’’ or ‘‘the 

GAP FAC’’) in accordance with the 

requirements of the Federal Advisory 

Committee Act (FACA). This meeting 

will be open to the public, accessible via 

webcast. Information on attending and 

providing written public comment is 

under the SUPPLEMENTARY INFORMATION

section. 

DATES: The GAP FAC will hold an open 

public meeting on Thursday, September 

21, 2023, from 3:00 p.m. to 4:00 p.m. 

Eastern Standard Time (EST). 

ADDRESSES: The meeting will be 

accessible via webcast. Registrants will 

receive the webcast information before 

the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Boris Arratia, Designated Federal 

Officer, OGP, 703–795–0816, or email: 

boris.arratia@gsa.gov; or Stephanie 

Hardison, OGP, 202–258–6823, or 

email: stephanie.hardison@gsa.gov. 

Additional information about the 

Committee, including meeting materials 

and agendas, are available on-line at 

https://gsa.gov/policy-regulations/ 

policy/acquisition-policy/gsaacquisition-policy-federal-advisorycommittee. 

SUPPLEMENTARY INFORMATION: 

Purpose of the Meeting 

The purpose of this meeting is for the 

GAP FAC to propose, discuss and vote 

on committee comments on the Federal 

Acquisition Regulation (FAR) Council’s 

Proposed Rule on Sustainable 

Procurement, which is available online 

at https://www.federalregister.gov/ 

documents/2023/08/03/2023-16012/ 

federal-acquisition-regulationsustainable-procurement. 

Meeting Agenda 

• Opening Remarks 

• Propose and discuss GAP FAC 

comments on the FAR Council’s 

Proposed Rule on Sustainable 

Procurement 

• Vote on GAP FAC comments 

• Closing Remarks and Adjourn 

Meeting Registration 

This meeting is open to the public 

and will be accessible by webcast. 

Registration information is located on 

the GAP FAC website: https://

www.gsa.gov/policy-regulations/policy/ 

acquisition-policy/gsa-acquisitionpolicy-federal-advisory-committee. 

Public attendees who want to attend 

virtually will need to register no later 

than 5:00 p.m. EST, on Wednesday, 

September 20, 2023 to obtain the 

meeting webcast information. All 

registrants will be asked to provide their 

name, affiliation, and email address. 

After registration, individuals will 

receive webcast access information 

details via email. 

Public Comments 

Written public comments are being 

accepted via email at gapfac@gsa.gov. 

To submit a written public comment, 

please email at gapfac.gsa.gov and 

include your name, organization name 

(if applicable). 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2023–19197 Filed 9–5–23; 8:45 am] 

BILLING CODE 6820–RV–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2023–0076] 

Advisory Committee on Immunization 

Practices 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice and request for comment. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices (ACIP). This meeting is open 

to the public. Time will be available for 

public comment. 

DATES: The meeting will be held on 

September 22, 2023, 10 a.m. to 5 p.m., 

EDT (date and times subject to change; 

see the ACIP website for updates: 

https://www.cdc.gov/vaccines/acip/ 

index.htm). 

Written comments will be received 

between September 7–21, 2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0076, by either of the methods listed 

below. CDC does not accept comments 

by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Ms. Stephanie Thomas, ACIP 

Meeting, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027. Attn: Docket No. CDC– 

2023–0076. 

Instructions: All submissions received 

must include the Agency name and 

docket number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

The meeting will be webcast live via 

the World Wide Web. The webcast link 

can be found on the ACIP website at 

https://www.cdc.gov/vaccines/acip/ 

index.html. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, Committee 

Management Specialist, Advisory 

Committee on Immunization Practices, 

National Center for Immunization and 

Respiratory Diseases, Centers for 

Disease Control and Prevention, 1600 


lotter on DSK11XQN23PROD with NOTICES1
60946 Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 

Clifton Road NE, Mailstop H24–8, 

Atlanta, Georgia 30329–4027. 

Telephone: (404) 639–8836; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: Purpose: 

The Advisory Committee on 

Immunization Practices (ACIP) is 

charged with advising the Director, 

Centers for Disease Control and 

Prevention (CDC), on the use of 

immunizing agents. In addition, under 

42 U.S.C. 1396s, the Committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under applicable provisions of the 

Affordable Care Act and Section 2713 of 

the Public Health Service Act, 

immunization recommendations of 

ACIP that have been approved by the 

Director, CDC, and appear on CDC 

immunization schedules generally must 

be covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions of maternal 

respiratory syncytial virus (RSV) 

vaccine. A recommendation vote for 

maternal RSV vaccine is scheduled. A 

Vaccines for Children vote is scheduled 

for maternal RSV vaccine. Agenda items 

are subject to change as priorities 

dictate. For more information on the 

meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web. For more information on ACIP, 

please visit the ACIP website: https://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near-duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on September 7, 2023. 

Written comments must be received by 

September 21, 2023. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the September 22, 

2023, ACIP meeting must submit a 

request between September 7, 2023, and 

September 20, 2023, at https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html no later than 11:59 p.m., 

EDT, September 20, 2023, according to 

the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

on September 21, 2023. To 

accommodate the significant interest in 

participation in the oral public 

comment session of ACIP meetings, 

each speaker will be limited to three 

minutes, and each speaker may only 

speak once per meeting. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–19135 Filed 9–5–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Lead Exposure and Prevention 

Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Lead Exposure and Prevention 

Advisory Committee (LEPAC). This is a 

hybrid meeting which will occur in 

person and online and is open to the 

public. Advance registration by 

September 29, 2023, is needed to 

receive the information to attend the 

meeting. The registration link is 

provided in the addresses section 

below. 

DATES: The meeting will be held on 

October 16, 2023, from 9 a.m. to 4:30 

p.m., EDT and October 17, 2023, from 

9 a.m. to 1 p.m., EDT. 

ADDRESSES: Register in advance at 

https://forms.office.com/pages/

responsepage.aspx?id=eCgFR53Gc0uxes

XQDXVJuPeyypfKOR5G

j2Gz6aPXBGpUREZISTBGV

jczTFlLRU5NUjY0SFN

aQTM0UC4u&web=1&wdLOR=

c61C32E80-28BF-40D7-AC2DE113AEFDAA23 to receive information 

to attend the meeting. 

FOR FURTHER INFORMATION CONTACT: Paul 

Allwood, Ph.D., M.P.H., Designated 

Federal Officer, National Center for 

Environmental Health, Centers for 

Disease Control and Prevention, 4770 

Buford Highway, Atlanta, Georgia 

30341, Telephone: 770–488–6774; 

Email: LEPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Lead Exposure and 

Prevention Advisory Committee was 

established under Section 2203 of 

Public Law 114–322, the Water 

Infrastructure Improvements for the 

Nation Act; 42 U.S.C. 300j–21, Registry 

for Lead Exposure and Prevention 

Advisory Committee. 

Purpose: The LEPAC is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services (HHS), and the 

Director, CDC and Administrator, 

ATSDR, on (1) reviewing Federal 

programs and services available to 

individual communities exposed to 

lead; (2) reviewing current research on 

lead exposure to identify additional 


lotter on DSK11XQN23PROD with NOTICES1